A comprehensive study on Industry 4.0 in the pharmaceutical industry for sustainable development.

Devansh Sharma, Prachi Patel, Manan Shah
Author Information
  1. Devansh Sharma: L.J. Institute of Pharmacy, Ahmedabad, Gujarat, India.
  2. Prachi Patel: L.J. Institute of Pharmacy, Ahmedabad, Gujarat, India.
  3. Manan Shah: Department of Chemical Engineering, School of Energy Technology, Pandit Deendayal Energy University, Gandhinagar, Gujarat, India. manan.shah@spt.pdpu.ac.in. ORCID

Abstract

The four evolutionary stages have brought us to Industry 4.0. Industry 4.0 is nothing but the 4th Industrial Revolution which will change the production processes. The implementation of Industry 4.0 in the pharmaceutical sector will make the manufacturing of complex drugs easier. The arrival of Industry 4.0 and its advanced technologies such as artificial intelligence (AI), robotics, and the Internet of Things (IoT) makes the processes flexible. Industry 4.0 was introduced to reduce the human workforce and make the complicated processes unchallenging. It is used in all aspects of pharmaceutical sector like analysis, diagnosis, manufacturing, and packaging. The main aim of this paper is to comprehensively elucidate how Industry 4.0 has played a significant role in sustainable development (SD). Industry 4.0 in sustainability decreases the research efforts and examines the research sector's opportunities. This paper also discusses the impact of Industry 4.0 on sustainable development. Industry 4.0 constructs a bridge between industry and sustainability leading to sustainable development. Sustainability can be achieved by adopting innovative techniques of Industry 4.0 in manufacturing. Moreover, Industry 4.0 provides potential benefits for enhancing pharmaceutical production concerning flexibility, expenses, standards, and safety. It is noticed that Industry 4.0 has a beneficial impact on sustainable development by implementing advanced technologies leading to flexible manufacturing processes.

Keywords

References

  1. Acioli C, Scavarda A, Reis A (2021) Applying Industry 4.0 technologies in the COVID���19 sustainable chains. Int J Product Perform Manag 70(5):988���1016. https://doi.org/10.1108/IJPPM-03-2020-0137 [DOI: 10.1108/IJPPM-03-2020-0137]
  2. Aksu B, Ye��en G (2021) Mini-review Industry 4.0 elements for pharmaceutical development and manufacture. J Health Sci A J Health Sci 3(1):45���50
  3. Arden NS, Fisher AC, Tyner K, Yu LX, Lee SL, Kopcha M (2021) Industry 4.0 for pharmaceutical manufacturing: preparing for the smart factories of the future. In International Journal of Pharmaceutics (Vol. 602). https://doi.org/10.1016/j.ijpharm.2021.120554
  4. Argiyantari B, Simatupang TM, Basri MH (2020) Pharmaceutical supply chain transformation through application of the lean principle: a literature review. J Ind Eng Manag 13(3):475���494. https://doi.org/10.3926/jiem.3100 [DOI: 10.3926/jiem.3100]
  5. Barenji RV, Akdag Y, Yet B, Oner L (2019) Cyber-physical-based PAT (CPbPAT) framework for Pharma 4.0. Int J Pharm 567(June):0���45. https://doi.org/10.1016/j.ijpharm.2019.06.036 [DOI: 10.1016/j.ijpharm.2019.06.036]
  6. Bianchi P, Dur��n C, Labory S (2019) Impact of Industry 4.0 on manufacturing. Transform Ind Policy Digit Age 11���11. https://doi.org/10.4337/9781788976152.00006
  7. Chiacchio F, D���Urso D, Compagno L, Chiarenza M, Velardita L (2019) Towards a blockchain based traceability process: a case study from pharma industry. IFIP Adv Inf Commun Technol 566:451���457. https://doi.org/10.1007/978-3-030-30000-5_56 [DOI: 10.1007/978-3-030-30000-5_56]
  8. Chiarini A (2021) Industry 4.0 technologies in the manufacturing sector: are we sure they are all relevant for environmental performance? Bus Strateg Environ 30(7):3194���3207. https://doi.org/10.1002/bse.2797 [DOI: 10.1002/bse.2797]
  9. Cimini C, Pezzotta G, Pinto R, Cavalieri S (2019) Industry 4.0 technologies impacts in the manufacturing and supply chain landscape: an overview. Stud Comput Intell 803:109���120. https://doi.org/10.1007/978-3-030-03003-2_8 [DOI: 10.1007/978-3-030-03003-2_8]
  10. da Silveira F, Neto IR, Machado FM, da Silva MP, Amaral FG (2019) Analysis of Industry 4.0 technologies applied to the health sector: systematic literature review. Stud Syst Decis Control 202:701���709. https://doi.org/10.1007/978-3-030-14730-3_73 [DOI: 10.1007/978-3-030-14730-3_73]
  11. Dai L (2006) From conventional technology to carbon nanotechnology. The fourth industrial revolution and the discoveries of C60, carbon nanotube and nanodiamond. Carbon Nanotechnol 3���11. https://doi.org/10.1016/B978-044451855-2/50004-8
  12. Ding B (2018) Pharma Industry 4.0: literature review and research opportunities in sustainable pharmaceutical supply chains. Process Saf Environ Prot 119:115���130. https://doi.org/10.1016/j.psep.2018.06.031 [DOI: 10.1016/j.psep.2018.06.031]
  13. Djunaedi (2019) Building social sustainability of pharmaceutical industry through Industry 4.0 implementation. Pol J Manag Stud 20(1):149���158. https://doi.org/10.17512/pjms.2019.20.1.13 [DOI: 10.17512/pjms.2019.20.1.13]
  14. Duvoisin C, Horst D, Sousa M (2018) Additive manufacturing at Industry 4.0: a review Cite this paper St at e-of-t he-Art Survey of AdditiveManufacturing Technologies, Met hods, and Mat erials. Int J Eng Tech Res 8:3. www.erpublication.org
  15. Gautam A, Pan X (2016) The changing model of big pharma: Impact of key trends. Drug Discov Today 21(3):379���384. https://doi.org/10.1016/j.drudis.2015.10.002 [DOI: 10.1016/j.drudis.2015.10.002]
  16. Giltinan D (1996) Getting ready for independence. Adopt Foster 20(1):59���60. https://doi.org/10.1177/030857599602000113 [DOI: 10.1177/030857599602000113]
  17. Grzybowska K, Lupicka A (2017) Economics & management innovations ( ICEMI ): key competencies for Industry 4.0. Volkson Press 1(1):250���253
  18. Henstock P (2020) Artificial intelligence in pharma: positive trends but more investment needed to drive a transformation. Arch Pharmacol Ther 2(2):24���28. https://doi.org/10.33696/pharmacol.2.017 [DOI: 10.33696/pharmacol.2.017]
  19. Industry, SG (n.d.) Sustainability Green Industry 4.0 | Encyclopedia MDPI. https://encyclopedia.pub/entry/1556
  20. Jones OAH, Voulvoulis N, Lester JN (2003) Potential impact of pharmaceuticals on environmental health. Bull World Health Organ 81(10):768���769
  21. Lakner Z, Kiss A, Popp J, Z��man Z, M��t�� D, Ol��h J (2019) From basic research to competitiveness: an econometric analysis of the global pharmaceutical sector. Sustain (switzerland) 11(11):1���17. https://doi.org/10.3390/su11113125 [DOI: 10.3390/su11113125]
  22. Lassila M (2020) Case study in the context of Pharma 4.0: binary pass / fail classification of pharmaceutical product batches based on raw material batch properties.
  23. Mostofi A, Jain V (2021) Inventory management and control of deteriorating pharmaceutical products sing Industry 4.0. 2021 IEEE 8th Int Conf Ind Eng Appl ICIEA 2021:394���400. https://doi.org/10.1109/ICIEA52957.2021.9436744 [DOI: 10.1109/ICIEA52957.2021.9436744]
  24. Northrup J (2005) The pharmaceutical sector. Bus Healthc Innov. https://doi.org/10.1017/CBO9780511488672.003 [DOI: 10.1017/CBO9780511488672.003]
  25. Peake BM, Braund R, Tong AYC, Tremblay LA (2016) Impact of pharmaceuticals on the environment. In The Life-Cycle of Pharmaceuticals in the Environment (Issue 1). Elsevier Ltd. https://doi.org/10.1016/b978-1-907568-25-1.00005-0
  26. Prajwal AT, Muddukrishna BS, Vasantharaju SG (2020) Pharma 4.0���impact of the internet of things on health care. Int J Appl Pharm 12(5):64���69. https://doi.org/10.22159/ijap.2020v12i5.38633 [DOI: 10.22159/ijap.2020v12i5.38633]
  27. Prajwal AT, Muddukrishna BS, Vasantharaju SG (2020) Pharma 4.0���impact of the internet of things on health care. Int J Appl Pharm 12(5):64���69. https://doi.org/10.22159/ijap.2020v12i5.38633 [DOI: 10.22159/ijap.2020v12i5.38633]
  28. Reinhardt IC, Oliveira DJC, Ring DDT (2020) Current perspectives on the development of Industry 4.0 in the pharmaceutical sector. J Ind Inf Integr 18(January):100131. https://doi.org/10.1016/j.jii.2020.100131 [DOI: 10.1016/j.jii.2020.100131]
  29. Reinhardt IC, Oliveira JC, Ring DT (2021) Industry 4.0 and the future of the pharmaceutical industry. Pharm Eng 1���11.
  30. Reis MS, Gins G (2017) Industrial process monitoring in the big data/industry 4.0 era: from detection, to diagnosis, to prognosis. Processes 5(3). https://doi.org/10.3390/pr5030035
  31. Rezeoa S (2021) Strategy and planning and implementation and impact for the pharmaceutical industry with and by Industry 4.0 by Stefan Rezepa :: SSRN. Lang Competence Part Lifelong Learn Book Sci Artic 4:1���14. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3955697
  32. Santos BP, Lima TM (2018) Industry 4.0: an overview. II.
  33. Sarfraz A, Sarfraz Z, Sarfraz M, Abdul Razzack A, Bano S, Singh Makkar S, Thevuthasan S, Paul T, Khawar Sana M, Azeem N, Felix M, Cherrez-Ojeda I (2022) Industry 4.0 technologies for the manufacturing and distribution of COVID-19 vaccines. J Prim Care Commun Health 13. https://doi.org/10.1177/21501319211068638
  34. Scherer FM (2000) Chapter 25 The pharmaceutical industry. Handb Health Econ 1(PART B):1297���1336. https://doi.org/10.1016/S1574-0064(00)80038-4 [DOI: 10.1016/S1574-0064(00)80038-4]
  35. Shi Z, Xie Y, Xue W, Chen Y, Fu L, Xu X (2020) Smart factory in Industry 4.0. Syst Res Behav Sci 37(4):607���617. https://doi.org/10.1002/sres.2704 [DOI: 10.1002/sres.2704]
  36. Silva F, Resende D, Amorim M, Borges M (2020) A field study on the impacts of implementing concepts and elements of industry 4.0 in the biopharmaceutical sector. J Open Innov Technol Market Complex 6(4):1���19. https://doi.org/10.3390/joitmc6040175 [DOI: 10.3390/joitmc6040175]
  37. Singh M, Sachan S, Singh A, Singh KK (2019) Internet of Things in pharma industry: possibilities and challenges. Elsevier Inc., In Emergence of Pharmaceutical Industry Growth with Industrial IoT Approach. https://doi.org/10.1016/B978-0-12-819593-2.00007-8 [DOI: 10.1016/B978-0-12-819593-2.00007-8]
  38. Sisodia A, Jindal R (2021) A meta-analysis of industry 4.0 design principles applied in the health sector. Eng Appl Artif Intell 104(June 2020):104377. https://doi.org/10.1016/j.engappai.2021.104377 [DOI: 10.1016/j.engappai.2021.104377]
  39. Steinwandter V, Borchert D, Herwig C (2019) Data science tools and applications on the way to Pharma 4.0. Drug Discov Today 24(9):1795���1805. https://doi.org/10.1016/j.drudis.2019.06.005 [DOI: 10.1016/j.drudis.2019.06.005]
  40. Thuemmler C, Bai C (2017) Health 4.0: how virtualization and big data are revolutionizing healthcare. Health 4.0 How Virtualization Big Data Are Revolutionizing Healthc 1���254. https://doi.org/10.1007/978-3-319-47617-9
  41. Ugvekar N, Kamath KK, Subramanyam EVS, Shabaraya AR (2021) A review on change management system in pharmaceutical industry. Nishi et al Int J Drug Regul Aff 9(3):37���41. https://doi.org/10.22270/ijdra.v9i3.482 [DOI: 10.22270/ijdra.v9i3.482]
  42. Wan J, Tang S, Li D, Imran M, Zhang C, Liu C, Pang Z (2019) Reconfigurable smart factory for drug packing in healthcare industry 4.0. IEEE Trans Ind Inf 15(1):507���516. https://doi.org/10.1109/TII.2018.2843811 [DOI: 10.1109/TII.2018.2843811]

MeSH Term

Humans
Artificial Intelligence
Commerce
Drug Industry
Sustainable Development

Word Cloud

Created with Highcharts 10.0.0Industry40developmentsustainableprocessespharmaceuticalmanufacturingsectorwillproductionmakeadvancedtechnologiesflexiblepapersustainabilityresearchimpactindustryleadingfourevolutionarystagesbroughtusnothing4thIndustrialRevolutionchangeimplementationcomplexdrugseasierarrivalartificialintelligenceAIroboticsInternetThingsIoTmakesintroducedreducehumanworkforcecomplicatedunchallengingusedaspectslikeanalysisdiagnosispackagingmainaimcomprehensivelyelucidateplayedsignificantroleSDdecreaseseffortsexaminessector'sopportunitiesalsodiscussesconstructsbridgeSustainabilitycanachievedadoptinginnovativetechniquesMoreoverprovidespotentialbenefitsenhancingconcerningflexibilityexpensesstandardssafetynoticedbeneficialimplementingcomprehensivestudyPharmaceuticalSustainable

Similar Articles

Cited By